Theses›Listed companies›KPRX

Kiora Pharmaceuticals

NASDAQ: KPRX · US

015254060+cheapfairfullexpensive 015254060+cheapfairfullexpensive
Fig. 1The screen as a ruler, with no pin: the company has no forward earnings or sales figure the screen can place yet. The table below has what market data there is.
Market datarefreshed 6 Nov 2026
Price1.44 USD
Market value$6M
Revenue, last 12 months—
Forward P/E-0.6x
EV to revenue—
Gross and operating margin0% · 0%

Not advice. Where I hold a position it is disclosed to members, with the reasoning.